Plaque Psoriasis Management

Introduction to Treatment

• Plaque psoriasis treatment guidelines recommend topical corticosteroids (alone or combined with vitamin D analogs) as first-line therapy for mild disease, with biologic agents recommended for moderate-to-severe disease that doesn't respond to topical therapy, as stated by the American Academy of Dermatology 1
• The American Academy of Dermatology and the European League Against Rheumatism emphasize the importance of prompt treatment to reduce symptoms and improve quality of life in patients with psoriatic arthritis 1, 2

First-Line Therapies

• High-potency topical corticosteroids (Class 1-2: clobetasol propionate, halobetasol propionate) and vitamin D analogs (calcipotriene/calcipotriol) are effective first-line topical therapies for plaque psoriasis, with combination products offering superior efficacy 1
• The following potency classes of topical corticosteroids are recommended:

1

• High-potency topical corticosteroids alone or in combination with vitamin D analogs are the most effective first-line treatments for scalp plaque psoriasis, as recommended by the American Academy of Dermatology 1

Second-Line Therapies

• Tazarotene (topical retinoid) is recommended for 8-12 weeks, best used in combination with corticosteroids to reduce irritation, for the treatment of plaque psoriasis 1
• Calcineurin inhibitors (tacrolimus 0.1%, pimecrolimus) are particularly effective for treating plaque psoriasis on the face and intertriginous areas 1
• Topical calcineurin inhibitors, such as tacrolimus 0.1% ointment, are recommended as first-line treatment for facial psoriasis due to their efficacy and safety profile in sensitive areas 3

Combination Therapies

• Combining corticosteroids with vitamin D analogs increases efficacy while reducing corticosteroid side effects for treating plaque psoriasis 1
• Combining tazarotene with corticosteroids reduces tazarotene irritation while enhancing efficacy and extending remission for treating plaque psoriasis 1
• The combination of tacrolimus and salicylic acid is an effective off-label treatment for plaque psoriasis 1

Biologic Therapies

• TNF inhibitors (etanercept, adalimumab) are recommended as first-line therapy for psoriatic arthritis, according to the European League Against Rheumatism 2, 4
• IL-17 inhibitors are preferred for patients with significant skin involvement, as recommended by the European League Against Rheumatism 2
• IL-12/23 inhibitors are also preferred for patients with significant skin involvement, according to the European League Against Rheumatism 2

Safety and Contraindications

• Tazarotene is absolutely contraindicated in pregnancy and requires a pregnancy test 2 weeks before starting in women of childbearing potential 1
• Calcineurin inhibitors carry an FDA boxed warning for theoretical malignancy risk, but there is no evidence of increased risk with topical use, and may cause burning or pruritus initially, which typically improves with continued use 1
• Regular monitoring for adverse effects is necessary, including skin atrophy, telangiectasia, and striae with corticosteroids, hepatotoxicity and bone marrow suppression with methotrexate, and infections and injection site reactions with biologics 5

Special Considerations

• Intertriginous areas require special attention, and first-line treatment includes topical calcineurin inhibitors (tacrolimus) or low-potency corticosteroids 6
• Genital psoriasis causes significant psychological impact and requires special attention 6
• Pediatric patients should use lower potency corticosteroids, particularly in children with ≥4 psoriasis-associated features 1
• Young children (0-6 years) are vulnerable to HPA suppression, and high-potency corticosteroids should be used with caution 3

Lifestyle and Supportive Therapies

• Regular topical skincare with emollients is recommended as a primary approach, as per the British Association of Dermatologists 7
• Meditation techniques, such as guided mindfulness meditation, may improve outcomes in patients with mild to moderate psoriasis, and biofeedback and relaxation techniques may improve symptoms in some patients with mild psoriasis 1
• Antihistamines or oral retinoids may be used for pruritus management, and topical and systemic therapy as needed for pain management, as per the British Association of Dermatologists 7

Treatment Evaluation and Monitoring

• Evaluate response after 4 weeks for topical therapy, and consider combination therapy to enhance efficacy and reduce side effects 1, 5, 8
• Vitamin D analogs may require 8 weeks for full efficacy, which may not be evident at 4 weeks, when evaluating the response to topical therapy for plaque psoriasis 1
• Disease severity can be classified as mild (<3% BSA), moderate (3-10% BSA), or severe (>10% BSA or involvement of high-impact areas) 1